Floatz logo

Acetylsalicylic Acid

Thrombosis

China National Center for Cardiovascular DiseasesPhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Thrombosis cohort.

Asset / SponsorPhaseRating
Rivaroxaban
Shanghai Zhongshan Hospital
Phase 4BBB
Apixaban
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB
Dabigatran
St. Antonius Hospital
Phase 4BB
WARFARIN
China National Center for Cardiovascular Diseases
Phase 4BB
Enoxaparin
Helsinki University Central Hospital
Phase 4BB

View all 24 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →